Bank of America
STLN

Bank of America’s Starling Oncology STLN Stock Holding History

Bank of America’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
391,997
+328,558
+518% +$1.38M ﹤0.01% 4170
2026
Q1 		$195K Buy
63,439
+16,991
+37% +$52.1K ﹤0.01% 5369
2025
Q4 		$165K Sell
46,448
-5,276
-10% -$19.6K ﹤0.01% 5425
2025
Q3 		$181K Buy
51,724
+25,916
+100% +$88.8K ﹤0.01% 6324
2025
Q2 		$52.9K Buy
25,808
+22,875
+780% +$57.2K ﹤0.01% 6788
2025
Q1 		$3.34K Buy
2,933
+15
+0.5% +$12 ﹤0.01% 7273
2024
Q4 		$902 Buy
2,918
+211
+8% +$55 ﹤0.01% 7306
2024
Q3 		$882 Buy
2,707
+36
+1% +$15 ﹤0.01% 7269
2024
Q2 		$1.23K Sell
2,671
-1,235
-32% -$1.05K ﹤0.01% 7200
2024
Q1 		$6.17K Sell
3,906
-28,334
-88% -$53.9K ﹤0.01% 6968
2023
Q4 		$65.8K Buy
32,240
+28,334
+725% +$49.1K ﹤0.01% 6521
2023
Q3 		$5.47K Sell
3,906
-2
-0.1% -$2 ﹤0.01% 6976
2023
Q2 		$2.15K Sell
3,908
-20,704
-84% -$11K ﹤0.01% 7130
2023
Q1 		$16.7K Sell
24,612
-7,383
-23% -$9.42K ﹤0.01% 6805
2022
Q4 		$52.8K Buy
31,995
+16,164
+102% +$45.4K ﹤0.01% 6462
2022
Q3 		$73K Buy
15,831
+9,580
+153% +$56.3K ﹤0.01% 6503
2022
Q2 		$31K Sell
6,251
-3,387
-35% -$24.7K ﹤0.01% 7040
2022
Q1 		$69K Buy
+9,638
New +$65K ﹤0.01% 7031
2021
Q4 		– Sell
-462,000
Closed -$4.59M – 8635
2021
Q3 		$4.59M Hold
462,000
– – ﹤0.01% 3645
2021
Q2 		$4.6M Buy
+462,000
New +$4.65M ﹤0.01% 3593

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America's STLN Position: Q2 2026 in Review

Bank of America increased its Starling Oncology (STLN) stake by 518% in Q2 2026, buying an estimated $1.38M and bringing the position to 391,997 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #4170.

Bank of America first reported a position in STLN in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.6M in Q2 2021. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Bank of America held 391,997 shares of Starling Oncology worth $2.13M as of Q2 2026.
  • Bank of America bought 328,558 Starling Oncology shares in Q2 2026, an estimated $1.38M.
  • Starling Oncology made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4170 holding.
  • Bank of America first reported a position in Starling Oncology in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Starling Oncology position peaked at $4.6M in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.